CIK: 0001952142
Total reported value
$522.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 8.29% | -1.55% | -4.94% | |
| 2 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 6.26% | — | -48.54% | |
| 3 | SRRK | Scholar Rock Holding CORP | Stock-Other | 5.80% | +3.08% | +112.62% | |
| 4 | ACLXGBX | Arcellx INC | Stock-Other | 5.73% | -3.72% | EXIT | |
| 5 | ✓ | Merus N V | Stock-Other | 4.65% | — | -43.60% | |
| 6 | IMVT | Immunovant INC | Stock-Other | 4.65% | — | -23.70% | |
| 7 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 4.32% | -1.77% | EXIT | |
| 8 | NUVL | Nuvalent Inc-a | Stock-Other | 4.30% | — | +31.10% | |
| 9 | RVMD | Revolution Medicines INC | Stock-Healthcare | 3.59% | +4.49% | +64.72% | |
| 10 | JANX | Janux Therapeutics INC | Stock-Other | 2.94% | — | +134.49% | |
| 11 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 2.94% | -1.11% | -26.93% | |
| 12 | DNLI | Denali Therapeutics INC | Stock-Other | 2.89% | — | +14.16% | |
| 13 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 2.72% | -4.95% | EXIT | |
| 14 | QURE | uniQure N.V. | Stock-Other | 2.47% | — | +712.27% | |
| 15 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 2.30% | — | — | |
| 16 | CGON | Cg Oncology INC | Stock-Other | 2.26% | +2.66% | NEW | |
| 17 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 2.24% | — | — | |
| 18 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 2.21% | — | -73.98% | |
| 19 | INSM | Insmed INC | Stock-Healthcare | 2.12% | — | -18.34% | |
| 20 | ALKS | Alkermes plc | Stock-Healthcare | 2.02% | — | -53.87% | |
| 21 | AKRO | Akero Therapeutics INC | Stock-Other | 2.02% | — | — | |
| 22 | BHVN | Biohaven Ltd. | Stock-Other | 1.92% | +2.58% | NEW | |
| 23 | CYTK | Cytokinetics INC | Stock-Healthcare | 1.92% | — | +79.06% | |
| 24 | 2655787D | Blueprint Medicines CORP | Stock-Other | 1.75% | — | — | |
| 25 | VTGN | Vistagen Therapeutics INC | Stock-Other | 1.63% | — | +1.63% | |
| 26 | TARA | Protara Therapeutic INC | Stock-Other | 1.62% | — | +258.18% | |
| 27 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.43% | — | -50.96% | |
| 28 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.34% | — | +73.51% | |
| 29 | SRZN | Surrozen INC | Stock-Other | 0.90% | — | -31.30% | |
| 30 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.76% | — | -65.25% | |
| 31 | ELVN | Enliven Therapeutics INC | Stock-Other | 0.76% | +2.73% | NEW | |
| 32 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 0.74% | — | — | |
| 33 | ASND | Ascendis Pharma A/S | Stock-Other | 0.73% | — | — | |
| 34 | ✓ | Helix Acquisition CORP Ii | Stock-Other | 0.72% | — | — | |
| 35 | SYRE | Spyre Therapeutics INC | Stock-Other | 0.70% | +1.44% | — | |
| 36 | AM6 | Amicus Therapeutics INC | Stock-Other | 0.70% | — | — | |
| 37 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.68% | — | — | |
| 38 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 0.58% | -1.08% | EXIT | |
| 39 | ABUS | Arbutus Biopharma CORP | Stock-Other | 0.52% | -0.81% | EXIT | |
| 40 | ✓ | Stock-Other | 0.49% | — | — | ||
| 41 | GERN | Geron CORP | Stock-Other | 0.49% | — | — | |
| 42 | IDYA | Ideaya Biosciences INC | Stock-Other | 0.35% | -0.96% | EXIT | |
| 43 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.30% | — | — | |
| 44 | OCUL | Ocular Therapeutix INC | Stock-Other | 0.29% | -1.09% | EXIT | |
| 45 | DYN | Dyne Therapeutics INC | Stock-Other | 0.28% | -1.04% | — | |
| 46 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 0.25% | — | — | |
| 47 | IFRX | InflaRx N.V. | Stock-Other | 0.24% | — | — | |
| 48 | SLDB | Solid Biosciences INC | Stock-Other | 0.23% | — | — | |
| 49 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.23% | — | -87.54% | |
| 50 | MBX | Mbx Biosciences INC | Stock-Other | 0.23% | +2.43% | — |